Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Mannkind Corp (MNKD)

Mannkind Corp (MNKD)
4.50 x 2 4.68 x 7
Pre-market by (Cboe BZX)
4.66 +0.02 (+0.43%) 04/11/25 [NASDAQ]
4.50 x 2 4.68 x 7
Pre-market 4.66 unch (unch) 16:00 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.54
Day High
4.71
Open 4.63
Previous Close 4.64 4.64
Volume 1,939,900 1,939,900
Avg Vol 2,170,290 2,170,290
Stochastic %K 34.58% 34.58%
Weighted Alpha -6.02 -6.02
5-Day Change -0.08 (-1.69%) -0.08 (-1.69%)
52-Week Range 3.97 - 7.63 3.97 - 7.63
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,415,918
  • Shares Outstanding, K 303,845
  • Annual Sales, $ 285,500 K
  • Annual Income, $ 27,590 K
  • EBIT $ 73 M
  • EBITDA $ 83 M
  • 60-Month Beta 1.22
  • Price/Sales 4.94
  • Price/Cash Flow 33.43
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 65.75% ( -55.94%)
  • Historical Volatility 30.14%
  • IV Percentile 53%
  • IV Rank 25.68%
  • IV High 229.09% on 04/30/24
  • IV Low 9.30% on 10/22/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1,518
  • Volume Avg (30-Day) 840
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 53,300
  • Open Int (30-Day) 50,298

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.03
  • Number of Estimates 1
  • High Estimate 0.03
  • Low Estimate 0.03
  • Prior Year 0.04
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.34 +7.37%
on 04/09/25
Period Open: 5.25
5.44 -14.34%
on 03/20/25
-0.59 (-11.24%)
since 03/11/25
3-Month
4.34 +7.37%
on 04/09/25
Period Open: 6.09
6.32 -26.27%
on 01/14/25
-1.43 (-23.48%)
since 01/10/25
52-Week
3.97 +17.38%
on 04/17/24
Period Open: 4.30
7.63 -38.93%
on 11/06/24
+0.36 (+8.37%)
since 04/11/24

Most Recent Stories

More News
MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options

MNKD : 4.66 (+0.43%)
MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22

MNKD : 4.66 (+0.43%)
MannKind Stock Surges After-Hours On Q4 Revenue Beat, Debt Reduction As Retail Investors Celebrate ‘Amazing Comeback’

The company significantly reduced its debt principal by $236 million, leaving just $36 million in remaining convertible debt, and ended 2024 with $203 million in cash, cash equivalents, and investments....

VXF : 160.66 (+1.55%)
MNKD : 4.66 (+0.43%)
XBI : 74.33 (+3.80%)
IWM : 184.36 (+1.46%)
MannKind (MNKD) Q4 2024 Earnings Call Transcript

MNKD earnings call for the period ending December 31, 2024.

MNKD : 4.66 (+0.43%)
MannKind: Q4 Earnings Snapshot

MannKind: Q4 Earnings Snapshot

MNKD : 4.66 (+0.43%)
MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

MNKD : 4.66 (+0.43%)
MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025

MNKD : 4.66 (+0.43%)
MannKind to Present at Upcoming Investor Conferences

MNKD : 4.66 (+0.43%)
MannKind Expands Executive Leadership Team

MNKD : 4.66 (+0.43%)
MannKind Corporation Reduces Debt by $194 Million and Strengthens Cash Position to Over $180 Million

MannKind Corporation reduces debt by $194 million and increases cash position to over $180 million through note exchanges.Quiver AI SummaryMannKind Corporation has announced a significant reduction in...

MNKD : 4.66 (+0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder...

See More

Key Turning Points

3rd Resistance Point 4.90
2nd Resistance Point 4.80
1st Resistance Point 4.73
Last Price 4.66
1st Support Level 4.56
2nd Support Level 4.47
3rd Support Level 4.40

See More

52-Week High 7.63
Fibonacci 61.8% 6.23
Fibonacci 50% 5.80
Fibonacci 38.2% 5.37
Last Price 4.66
52-Week Low 3.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar